NuWays sets Readcrest Capital price target at EUR 2.8, starts with buy rating

PUBT · 2d ago
NuWays sets Readcrest Capital price target at EUR 2.8, starts with buy rating
  • NuWays initiated coverage of Readcrest Capital with a BUY rating, setting a 12-month target price of EUR 2.8.
  • Sum-of-the-parts valuation implied EUR 2.19 per share for the UK domiciliary care unit, net of group debt and a holding discount.
  • Report highlighted FY25 revenue of EUR 128 million, EBITDA of EUR 12.5 million at TV Healthcare’s GHSC platform.
  • German residential-led development pipeline seen at EUR 658 million gross development value through FY31, with EUR 474 million attributable.
  • Key risks flagged: permitting on two projects, incomplete creditor workouts, replacement capital needs to refinance legacy project lenders.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Readcrest Capital AG published the original content used to generate this news brief via EQS News (Ref. ID: rc_26560) on August 18, 2026, and is solely responsible for the information contained therein.